PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Al Massadi, O.* ; López, M.* ; Tschöp, M.H. ; Dieguez, C.* ; Nogueiras, R.*

Current understanding of the hypothalamic ghrelin pathways inducing appetite and adiposity.

Trends Neurosci. 40, 167-180 (2017)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Ghrelin is a multifaceted regulator of metabolism. Ghrelin regulates energy balance in the short term via induction of appetite and in the long term via increased body weight and adiposity. Recently, several central pathways modulating the metabolic actions of ghrelin were unmasked, and it was shown to act through different hypothalamic nuclei to induce feeding. Ghrelin also modulates glucose homeostasis, but the central mechanisms responsible for this action have not been studied in detail. Although ghrelin also acts through extrahypothalamic areas to promote feeding, this review specifically dissects hypothalamic control of ghrelin's orexigenic and adipogenic actions and presents current understanding of the intracellular ghrelin orexigenic pathways, including their dependence on other relevant systems implicated in energy balance. The lack of ghrelin in adulthood has no effect on feeding or body weight. Ghrelin- or ghrelin receptor-deficient mice fed a high-fat diet after weaning and neuronal deletion of ghrelin receptor are diet-induced resistant. Ghrelin inhibition before weaning caused increased adiposity and feeding.Energy sensors controlling neuronal function and plasticity are located in the hypothalamus and ghrelin acts through these energy sensors to modulate feeding.The orexigenic but not the adipogenic action of ghrelin is impaired in obese animals.Mutations in the ghrelin receptor that prevented its binding to beta-arrestin did not influence ghrelin orexigenic action but increased its effects on adiposity and insulin resistance.Ghrelin's actions on energy and glucose homeostasis are of clinical relevance: ghrelin agonists show beneficial effects in patients with cancer cachexia; and an agonist of des-acyl ghrelin improves insulin sensitivity in humans.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
11.124
3.187
9
51
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Adiposity ; Fatty Acids ; Feeding ; Ghrelin ; Ghrelin Receptor ; Hypothalamus
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 0166-2236
e-ISSN 1878-108X
Zeitschrift Trends in Neurosciences
Quellenangaben Band: 40, Heft: 3, Seiten: 167-180 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Amsterdam [u.a.]
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Obesity (IDO)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502200-001
PubMed ID 28108113
DOI 10.1016/j.tins.2016.12.003
Scopus ID 85009766186
Erfassungsdatum 2017-03-09
[➜Korrektur melden]